Editas Medicine (EDIT) Net Margin Growth (3y) (2018 - 2025)
Editas Medicine (EDIT) Net Margin Growth (3y) (2018 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
49,253.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
506.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Editas Medicine |
262.77 Mn |
262.77 Mn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
13.24 Mn |
| Jun 30, 2025 |
-59,482.00 |
| Mar 31, 2025 |
-88,177.00 |
| Dec 31, 2024 |
18,398.00 |
| Sep 30, 2024 |
-10.12 Mn |
| Jun 30, 2024 |
140,060.00 |
| Mar 31, 2024 |
-458,548.00 |
| Dec 31, 2023 |
51,592.00 |
| Sep 30, 2023 |
-85,613.00 |
| Jun 30, 2023 |
-117,603.00 |
| Mar 31, 2023 |
17,747.00 |
| Dec 31, 2022 |
-62,175.00 |
| Sep 30, 2022 |
-13.18 Mn |
| Jun 30, 2022 |
60,616.00 |
| Mar 31, 2022 |
67,108.00 |
| Dec 31, 2021 |
7,714.00 |
| Sep 30, 2021 |
-52,601.00 |
| Jun 30, 2021 |
-1.41 Mn |
| Mar 31, 2021 |
-8,534.00 |
| Dec 31, 2020 |
43,956.00 |
